author-photo

Ingrid Jantzen

6

Papers

66

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

MPS VI associated ocular phenotypes in an MPS VI murine model and the therapeutic effects of odiparcil treatment.

2021 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Odiparcil is a promising substrate reduction therapy in MPS VI murine model

2018 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (4)
In vitro and in vivo activity of IVA336, a potential substrate reduction therapy, in mucopolysaccharidosis models

2017 Molecular Genetics and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
The New Generation Pan-Ppar Agonist Iva337 Protects the Liver from Metabolic Disorders and Fibrosis

2016 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (3)